TriSalus Life Sciences, Inc. TLSI Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s other accrued liabilities?
- TriSalus Life Sciences, Inc. (TLSI) reported other accrued liabilities of $269K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s other accrued liabilities changed year-over-year?
- TriSalus Life Sciences, Inc.'s other accrued liabilities decreased by 36.9% year-over-year, from $426K to $269K.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s other accrued liabilities?
- Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s other accrued liabilities has grown at a 18.1% compound annual growth rate (CAGR), from $142K to $234K.
- What does other accrued liabilities mean?
- This captures miscellaneous short-term obligations that do not fit into standard categories like accounts payable or accrued compensation. It often includes items such as customer deposits, short-term tax provisions, or other minor contractual liabilities. It provides insight into the breadth of the company's short-term financial commitments.